Method for preparing acylated crosslinked glycosaminoglycans
A method of preparing a hydrogel product including crosslinked glycosaminoglycan molecules, said method including: i) providing a glycosaminoglycan crosslinked by amide bonds, wherein the crosslinked glycosaminoglycans include residual amine groups; and ii) acylating residual amine groups of the crosslinked glycosaminoglycans provided in i) to form acylated crosslinked glycosaminoglycans.
1. A method of preparing a hydrogel product comprising acylating crosslinked glycosaminoglycans comprising residual amine groups to form acylated crosslinked glycosaminoglycans, wherein:
the hydrogel product comprises the acylated crosslinked glycosaminoglycan:
the crosslinked glycosaminoglycan comprises amide bonds between activated carboxyl groups of an activated glycosaminoglycan and 2′-amino groups of an at least partially deacetylated glycosaminoglycan with a coupling agent: and
the residual amine groups are amino groups of the at least partially deacetylated glycosaminoglycan.
2. The method according to claim 1 , wherein the crosslinked glycosaminoglycans are prepared according to a method comprising:
obtaining a solution comprising the at least partially deacetylated glycosaminoglycan and optionally a second glycosaminoglycan;
activating carboxyl groups on the at least partially deacetylated glycosaminoglycan and/or the optional second glycosaminoglycan with a coupling agent, to form activated glycosaminoglycans;
crosslinking the activated glycosaminoglycans via their activated carboxyl groups using amino groups of the at least partially deacetylated glycosaminoglycans to form the crosslinked glycosaminoglycans by amide bonds.
3. The method according to claim 2 , wherein the at least partially deacetylated glycosaminoglycan is selected from the group consisting of deacetylated hyaluronic acid, deacetylated chondroitin and deacetylated chondroitin sulfate, and mixtures thereof.
4. The method according to claim 2 , wherein the at least partially deacetylated glycosaminoglycan is deacetylated hyaluronic acid.
5. The method according to claim 2 , wherein the at least partially deacetylated glycosaminoglycan has a degree of acetylation of 99% or less, and a weight average molecular weight of 0.1 MDa or more.
6. The method according to claim 2 , wherein the at least partially deacetylated glycosaminoglycan is obtained by a method comprising:
obtaining a glycosaminoglycan comprising N-acetyl groups;
allowing the glycosaminoglycan comprising N-acetyl groups to react with hydroxylamine (NH 2 OH) or a salt thereof at a temperature of 100° C. or less for 2-200 hours to form an at least partially deacetylated glycosaminoglycan; and
recovering the at least partially deacetylated glycosaminoglycan.
7. The method according to claim 2 , wherein the second glycosaminoglycan is selected from the group consisting of hyaluronic acid, chondroitin and chondroitin sulfate, and mixtures thereof.
8. The method according to claim 2 , wherein the second glycosaminoglycan is hyaluronic acid.
9. The method according to claim 2 , wherein the coupling agent is a peptide coupling reagent.
10. The method according to claim 9 , wherein the coupling reagent is DMTMM.
11. The method according to claim 1 , wherein acylating the crosslinked glycosaminoglycans comprises acetylating residual amine groups of the crosslinked glycosaminoglycans to form acetylated crosslinked glycosaminoglycans.
12. The method according claim 1 , further comprising:
subjecting the crosslinked glycosaminoglycans to alkaline treatment to hydrolyze ester crosslinks formed as byproducts during the amide crosslinking.